NATIXIS - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q2 2023$21,587
+11.7%
2,623
-1.6%
0.00%
Q1 2023$19,329
-18.3%
2,6660.0%0.00%
Q4 2022$23,647
-98.5%
2,666
-96.9%
0.00%
-100.0%
Q1 2022$1,610,000
-28.5%
84,666
-0.1%
0.01%
-25.0%
Q4 2021$2,251,000
-35.4%
84,7930.0%0.01%
-33.3%
Q3 2021$3,483,000
-34.0%
84,793
-9.0%
0.01%
-47.8%
Q2 2021$5,277,000
+20.9%
93,159
-10.3%
0.02%
+64.3%
Q1 2021$4,363,000103,8870.01%
Other shareholders
EDITAS MEDICINE INC shareholders Q3 2021
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders